๐ Discovery of N-(benzo[1,2,3]triazol-1-yl)-N-(benzyl)acetamido)phenyl) carboxamides as severe acute respiratory syndrome coronavirus (SARS-CoV) 3CLpro inhibitors: Identification of ML300 and noncovalent nanomolar inhibitors with an induced-fit binding
Herein we report the discovery and SAR of a novel series of SARS-CoV 3CLpro inhibitors identified through the NIH Molecular Libraries Probe Production Centers Network (MLPCN). In addition to ML188, ML300 represents the second probe declared for 3CLpro from this collaborative effort. The X-ray structure of SARS-CoV 3CLpro bound with a ML300 analog highlights a unique induced-fit reorganization of the S2-S4 binding pockets leading to the first sub-micromolar noncovalent 3CLpro inhibitors retaining a single amide bond. ยฉ 2013 Elsevier Ltd.
keywords
author
๐ค Turlington, Mark
๐ค Chun, Aspen
๐ค Tomar, Sakshi
๐ค Eggler, Aimee
๐ค Grum-Tokars, Valerie
๐ค Jacobs, Jon
๐ค Daniels, J. Scott
๐ค Dawson, Eric
๐ค Saldanha, Adrian
๐ค Chase, Peter
๐ค Baez-Santos, Yahira M.
๐ค Lindsley, Craig W.
๐ค Hodder, Peter
๐ค Mesecar, Andrew D.
๐ค Stauffer, Shaun R.
year
โฐ 2013
issn
๐ 0960894X 14643405
volume
23
number
22
page
6172-6177
citedbycount
12
download
๐ [BibTeX]